Asset Detail: DUPIXENT® (dupilumab) in Moderate-to-Severe Asthma

Asset Information

Source Context: This media is attached to the document DUPIXENT MYWAY PORTAL .

Usage: Authorized for internal review, study guides, and academic presentations. Please cite the original document when embedding this asset.